Profile
AADI VRTX VRNA REGN ALNY ARGX
Company Name Aadi Bioscience, Inc. Vertex Pharmaceuticals Incorporated Verona Pharma plc Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $94.89M $108.04B $72.68B $67.32B $58.93B $52.28B
Employees 0.05K 6.10K 0.21K 15.16K 2.23K 1.60K
CEO David J. Lennon Reshma Kewalramani FASN, David S. Zaccardelli Leonard S. Schleifer Yvonne L. Greenstreet Timothy Van Hauwermeiren EMBA,
Ratings
AADI VRTX VRNA REGN ALNY ARGX
Quant Rating Score 2 3 1 4 2 4
Quant Rating Sell Neutral Strong Sell Buy Sell Buy
Trading
AADI VRTX VRNA REGN ALNY ARGX
Last Close $2.05 $409.47 $106.91 $657.53 $442.7 $854.65
High 52 $3.73 $516.74 $106.91 $828.42 $491.09 $854.65
Low 52 $1.9 $366.54 $35.37 $482.92 $224.58 $532.27
Price vs. 52 Week High -45.04 % -20.76 % 0 % -20.63 % -9.85 % 0 %
Price vs. 52 Week Low 7.89 % 11.71 % 202.26 % 36.16 % 97.12 % 60.57 %
Total Return
AADI VRTX VRNA REGN ALNY ARGX
1 Month Return 0 % -2.77 % 0 % 16.59 % -1.82 % 6.92 %
3 Month Return 0 % 11.71 % 1.53 % 16.8 % 0.9 % 29.13 %
6 Month Return 0 % -4.69 % 61.35 % 20.06 % 71.36 % 50.17 %
9 Month Return -25.99 % -12.75 % 77.41 % -7.33 % 60.29 % 32.17 %
YTD Return -35.02 % 1.68 % 130.21 % -7.69 % 88.13 % 38.97 %
1 Year Return -3.53 % -20.76 % 177.11 % -20.63 % 59.57 % 43.4 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AADI VRTX VRNA REGN ALNY ARGX
Dividend Yield Percentage (TTM) - - - 0.41 % - -
Dividend Paid and Capex Coverage Ration (TTM) -103.2 % 11.09 % -147.93 % 4.25 % 5.97 % 65.28 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 6.06 % - -
Growth
AADI VRTX VRNA REGN ALNY ARGX
Asset Growth -46.9 % 53.91 %
Gross Profit Growth 6.56 % 5941.02 %
Revenue Growth 6.69 % -
Revenue 3 Year 667.07 % -23.33 %
Revenue 5 Year 247.81 % 290254.46 %
Revenue 10 Year - -
EBIT Growth 1.09 % -162.64 %
Net Income Growth 3.15 % -218.96 %
Net Income 3 Yeari Growth Per Share 80.87 % -126.38 %
Net Income 5 Yeari Growth Per Share 72.56 % 33.14 %
Net Income 10 Yeari Growth Per Share -14739.26 % -7.28 %
Operating Income Growth 6.22 % -127.96 %
Operating Cash Flow Growth (CFG) 0.19 % -143.33 %
Operating 3 Year CFG 12.19 % -166.57 %
Operating 5 Year CFG 74.97 % 55.51 %
Operating 10 Year CFG -16973.01 % 41.1 %
EPS Growth 3.28 % -200 %
EPS Diluted Growth 3.28 % -215.05 %
Book Value Per Share -50.24 % -24.01 %
Share Holder 3 Year Equity Growth Per Share -87.28 % 0.26 %
Share Holder 5 Year Equity Growth Per Share -85.6 % -25.62 %
Share Holder 10 Year Equity Growth Per Share 2363.4 % -72.3 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share -100 % -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -34.25 % 139.05 %
Free Cash Flow Growth 3.82 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
AADI VRTX VRNA REGN ALNY ARGX
Gross Profit Margin TTM -23.62 % 86.11 % 95.15 % 85.39 % 51.22 % 65.82 %
Return on Assets TTM -5.76 % 15.13 % -14.17 % 11.4 % 0.9 % 15.06 %
Return on Equity TTM -8.09 % 22.14 % -38.66 % 15.31 % 26.13 % 18.96 %
Return on Capital Employed TTM -59.47 % 19.72 % -10.74 % 10.32 % 8.03 % 5.04 %
Net Income Per EBT TTM 100 % 83.16 % 111.3 % 88.98 % -136.38 % 237.3 %
EBT Per Ebit TTM 10.18 % 111.48 % 130.22 % 139.5 % -12.07 % 147.38 %
EBIT Per Revenue TTM -473.83 % 34.36 % -25.27 % 25.89 % 8.25 % 13.47 %
Cash Flow To Debt Ratio TTM - 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Receivables Turnover TTM - 6.03 2.55 2.51 3.33 1.91
Payables Turnover TTM 8 3.59 3.13 2.3 2.69 0.9
Inventory Turnover TTM - 1.06 1.25 0.64 4.2 2.26
Fixed Asset Turnover TTM 239955.56 % 431.08 % 8642.22 % 284.82 % 463.12 % 5009.77 %
Asset Turnover TTM 11.94 % 47.51 % 38.7 % 35.47 % 66.16 % 31.97 %
Operating Cash Flow Per Share TTM -1.38 14.98 -0.85 48.94 2.02 5.67
Free Cash Flow Per Share TTM -1.4 13.63 -0.85 40.09 1.68 5.58
Cash Per Share TTM 256.5 % 2486.48 % 511.44 % 8148.65 % 2072.79 % 5536.58 %
Operating Cash Flow Sales Ratio TTM -442.49 % 33.68 % -32.7 % 35.59 % 8.28 % 17.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.97 % 90.99 % 100.75 % 81.92 % 83.26 % 98.47 %
Cash Flow Coverage Ratios TTM - 251.83 % -29.66 % 187.43 % 20.32 % 932.29 %
Price To Free Cash Flows Ratio TTM -1.1 30.87 -995.27 16.2 266.2 130.44
Price To Operating Cash Flows Ratio TTM -1.63 28.12 -126.33 13.32 222.27 148.99
Price Cash Flow Ratio TTM -1.63 28.12 -126.33 13.32 222.27 148.99
Income Statement (TTM)
AADI VRTX VRNA REGN ALNY ARGX
Revenue $0.03B $11.02B $0.03B $14.2B $2.25B $2.19B
Gross Profit $0.02B $9.49B $0.03B $12.23B $1.92B $1.96B
Gross Profit Ratio 88.36% 86.11% 93.89% 86.13% 85.62% 89.62%
EBITDA $-0.06B $0.49B $-0.12B $5.32B $-0.18B $0.11B
Net Income $-0.06B $-0.54B $-0.14B $4.41B $-0.28B $0.83B
EPS Diluted -2.36 -2.08 -1.73 38.34 -2.18 12.78
Balance Sheet (MRQ)
AADI VRTX VRNA REGN ALNY ARGX
Long Term Debt $0B $1.66B $0.12B $2.7B $2.59B $0.03B
Total Liabilities $0.02B $6.12B $0.27B $8.41B $4.23B $0.7B
Total Equity $0.05B $16.41B $0.2B $29.35B $0.07B $5.5B
Total Investments $0.02B $6.65B $0.02B $15.42B $1.8B $1.93B
Total Debt $0B $1.75B $0.12B $2.7B $2.74B $0.04B
Total Assets $0.07B $22.53B $0.47B $37.76B $4.3B $6.2B
Cash Flow Statement (TTM)
AADI VRTX VRNA REGN ALNY ARGX
Net Income $-0.06B $-0.54B $-0.17B $4.41B $-0.28B $0.83B
Inventory $0B $-0.52B $-0.01B $-0.62B $0.01B $-0.1B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $-0.12B $4.42B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0B $-0.76B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AAPG 31.73
AARD Aardvark Therapeutics, Inc. Common Stock 10.14
ABCL AbCellera Biologics Inc. 3.91
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.2
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.88
ABPWW 0.0189
ABSI Absci Corporation 3.335
ABUS Arbutus Biopharma Corporation 4.5
ABVC ABVC BioPharma, Inc. 2.91
ABVX Abivax SA American Depositary Shares 105.27
ACAD ACADIA Pharmaceuticals Inc. 22.57
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6396
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.59
ACIU AC Immune SA 3.3
ACLX Arcellx, Inc. 86.55
ETFs With Exposure to AADI
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.00791 54.54
IWM iShares Russell 2000 ETF 0.00002 241.61
VTI Vanguard Total Stock Market Index Fund 0.00005 330.09
XBI SPDR S&P Biotech ETF 0.05 108.96
VT Vanguard Total World Stock Index Fund 0.00074 138.83
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 146.51
ACWF iShares MSCI Global Multifactor ETF 0.02786 32.7935
VXUS Vanguard Total Intl Stock Idx Fund 0.00221 74.2
VSS Vanguard FTSE All-World ex-US Small Capital Index Fund 0.02467 140.23
IWN iShares Russell 2000 Value ETF 0.00004 175.79
LABU Direxion Daily S&P Biotech Bull 3X Shares 0.01 117.62
IWO iShares Russell 2000 Growth ETF 0.00934 321.04
TLTE FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.0114 64.18
VXF Vanguard Extended Market Index Fund 0.00113 208
HDG ProShares Hedge Replication ETF 0.000190685 51.435
UWM ProShares Ultra Russell2000 0.000380553 45.73
IWC iShares Micro-Cap ETF 0.00939 149.27
URTY ProShares UltraPro Russell2000 0.000180747 51.4
XSOE WisdomTree Emerging Markets ex-State-Owned Enterprises Fund 0.06829 38.6
VTWV Vanguard Russell 2000 Value Index Fund 0 154.844
BTEC Principal Healthcare Innovators ETF 0.0272886 39.49
SBIO ALPS Medical Breakthroughs ETF 0.0009 44.17
VFLQ Vanguard U.S. Liquidity Factor ETF 0.09 99.7611
VTWO Vanguard Russell 2000 Index Fund 0 97.68
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00015 112.26
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00015 112.24
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00004 52.76
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00004 52.75
VBINX Vanguard Balanced Index Fund Investor Shares 0.00004 52.75
RYLD Global X Russell 2000 Covered Call ETF 0 15.33
AVEM Avantis Emerging Markets Equity ETF 0.03 76.58
DFAU Dimensional US Core Equity Market ETF 0.000457 45.97
DFAT Dimensional U.S. Targeted Value ETF 0.0000039245 57.02
DFAS Dimensional U.S. Small Cap ETF 0.00009244 67.61
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000202 38.62
VTSAX Vanguard Total Stock Market Index Fund 0.00005 160.66
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
VTSNX Vanguard Total Intl Stock Idx Fund 0.00221 159.15
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00113 157.74
VITSX Vanguard Total Stock Market Index Fund 0.00005 160.69
AVSE Avantis Responsible Emerging Markets Equity ETF 0.03 64.6
AVES Avantis Emerging Markets Value ETF 0.05 57.7444
DFSU Dimensional US Sustainability Core 1 ETF 0.0009425 42.49
VFSAX Vanguard FTSE All-World ex-US Small-Cap Index Fund Admiral Shares 0.02467 34.68
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000729842 16.27
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00113 157.75
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.00791 45.21
VTIAX Vanguard Total International Stock Index Fd Admiral 0.00221 39.8
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00112634 39.41
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0.00074 49.12
TYNE Direxion Nanotechnology ETF 0.453966 17.2638
AVSC Avantis U.S. Small Cap Equity ETF 0 56.44
GLOF iShares Trust - iShares Global Equity Factor ETF 0.02786 51.965
VGE.AX Vanguard FTSE Emerging Markets Shares ETF 0.00785 92.71
DCOR Dimensional ETF Trust 0.00000627 72.1
VEMPX Vanguard Extended Market Index InstlPlus 0.00113 389.28
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.00791 114.36
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00005 301.43
AVXC Avantis Emerging Markets ex-China Equity ETF 0.05 61.8947
VTWIX Vanguard Total World Stock Index I 0.00074 283.17
RSSL Global X Funds 0 94
VTPSX Vanguard Total Intl Stock Idx InstlPls 0.00221 159.19
Unlock